COMMUNIQUÉS West-GlobeNewswire

Echo IQ Announces EchoSolv AS Deployed into Mount Sinai Health System
30/04/2026
EchoSolv AS deployed into Mount Sinai Health System, a leading US health system in New York Mount Sinai Health System comprises seven hospitals, over 400 outpatient practices and +3,760 beds Mount Sinai Fuster Heart [...]
Nyxoah Participera à la Conférence Bank of America 2026 Healthcare
30/04/2026
Nyxoah Participera à la Conférence Bank of America 2026 Healthcare Mont-Saint-Guibert, Belgique – 30 avril 2026, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « Société »), une [...]
TLX101-Px (Pixlumi®) MAA Accepted in Europe
30/04/2026
MELBOURNE, Australia and INDIANAPOLIS, May 01, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the marketing authorization application (MAA) filed in Europe [...]
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody
30/04/2026
Novel dual-mechanism anti-IgE antibody designed to improve upon existing and emerging therapies for IgE-mediated diseases Cue Biopharma plans to initiate global Phase 2b trial in food allergy following anticipated [...]
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference
30/04/2026
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference Mont-Saint-Guibert, Belgium – April 30, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a [...]
Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
30/04/2026
GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable [...]
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
30/04/2026
SAN JOSE, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, [...]
Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company
30/04/2026
Proven immunology-focused executive and physician-scientist who has led companies from inception to IPO, driven multiple regulatory approvals, and helped build multi-billion-dollar therapeutic portfolios BOSTON, April [...]
The Ensign Group Acquires Real Estate and Expands Operations in Texas
30/04/2026
SAN JUAN CAPISTRANO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign TM group of companies, which invest in and provide skilled nursing and senior [...]
Leo International Precision Health AG Reports 2025 Results and Establishes Strategic Foundation for AI-Driven Precision Health Platform
30/04/2026
Planegg/Martinsried, Germany, April 30, 2026 – Leo International Precision Health AG (“LIPH” or the “Company”, ticker symbol: LEOW), a holding company building a global integrated AI-driven healthcare ecosystem, today [...]
FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update
30/04/2026
On track for first patient dosed in phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers in Q2 of 2026 HOUSTON, April 30, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a [...]
Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026
30/04/2026
SOUTH SAN FRANCISCO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for [...]
MyGriefAngels.org Launches "Grief @ Work Insights" Hub to Bridge the Support Gap in the Modern Workplace
30/04/2026
The groundbreaking free resource equips grieving employees and forward-thinking organizations worldwide with the policies, legislation, research, and compassionate guidance needed to navigate loss in the modern [...]
Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
30/04/2026
GAITHERSBURG, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its first quarter 2026 [...]
Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference
30/04/2026
Primary and subgroup analysis from the Phase 2b CORAL trial of nalbuphine ER for the treatment of patients with IPF-related chronic cough accepted for oral presentation, including key subgroup analyses by baseline cough [...]
Akebia Therapeutics to Report First Quarter 2026 Financial Results and Discuss Recent Business Highlights
30/04/2026
Akebia to Host Conference Call on May 7 at 8:00 a.m. EDT CAMBRIDGE, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the [...]
Alvotech Announces a Change in its Executive Team
30/04/2026
REYKJAVIK, Iceland, April 30, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, [...]
CooperCompanies Announces Release Date for Second Quarter 2026
30/04/2026
SAN RAMON, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report second quarter 2026 financial results on Thursday, June 4, [...]
HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
30/04/2026
MIRAMAR, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to [...]

Pages